BUSINESS WIRE
SANTA ANA, Calif.--(BUSINESS WIRE)--April 15, 2008--Advanced
Medical Optics, Inc. (AMO) (NYSE:EYE), a global leader in ophthalmic
surgical devices and eye care products, today announced it has won the
Omega NorthFace ScoreBoard Award(SM) for consistently exceeding
customer expectations. This marks the seventh time AMO, or VISX, Inc.,
which AMO acquired in 2005, has received the award.
The NorthFace ScoreBoard Award is presented annually by the Omega
Management Group Corp. to companies who achieved excellence in
customer satisfaction during the prior calendar year. A total of 27
companies qualified to receive the award for 2007.
Omega's methodology measures customer satisfaction and loyalty
levels for all clients on a five point scale a minimum of twice during
the calendar year in such categories as technical support, field
service, customer service and account management. NorthFace ScoreBoard
Award recipients are companies who, based on survey responses from
their own customers, achieved a 4.0 or above out of a possible 5.0.
"Receiving this award for the seventh time clearly demonstrates
AMO's commitment to achieving customer loyalty through exemplary
service," said AMO Senior Vice President, Global Customer Services
Angelo Rago. "It further demonstrates AMO's strength of process
integration to take the award-winning VISX customer culture and make
it standard for service across the organization. Our goal is to
continually look at ways to innovate and improve upon the customer
experience. The NorthFace ScoreBoard Award validates what we've been
working toward, which is to create value by constantly innovating and
evolving to meet the needs of our customers. We are honored to be
recognized by Omega for this achievement."
AMO will formally receive the award during ceremonies on May 15 at
Omega's SCORE Conference 2008 at the Boston World Trade Center. For
more information on Omega and SCORE Conference 2008, visit
www.omegascoreboard.com or call (866) 610-6700.
About Advanced Medical Optics (AMO)
AMO is focused on providing the full range of advanced refractive
technologies and support to help eye care professionals deliver
optimal vision and lifestyle experiences to patients of all ages.
Products in the cataract/implant line include intraocular lenses
(IOLs), phacoemulsification systems, viscoelastics, and related
products used in ocular surgery. AMO owns or has the rights to such
product brands as ReZoom(R), Tecnis(R), Clariflex(R), Sensar(R), and
Verisyse(R) IOLs, Sovereign(R), Sovereign(R) Compact and WhiteStar
Signature(TM) phacoemulsification systems with WhiteStar(R)
technology, Healon(R) viscoelastics, and the Baerveldt(R) glaucoma
shunt. Products in the laser vision correction line include wavefront
diagnostic devices, femtosecond lasers and associated patient
interface devices, and excimer laser vision correction systems and
treatment cards. AMO brands in the laser vision correction business
include Star S4 IR(R), WaveScan Wavefront(R), Advanced CustomVue(R),
IntraLase(R), IntraLasik(R) and iLasik (TM). Products in the eye care
line include dry eye drops and contact lens disinfecting solutions,
enzymatic cleaners and lens rewetting drops. Among the eye care
product brands the company possesses are COMPLETE(R), COMPLETE(R)
Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R),
UltraCare(R), Ultrazyme(R), Total Care(TM) and blink(TM) branded
products. AMO is based in Santa Ana, California, and employs
approximately 4,000 worldwide. The company has operations in 24
countries and markets products in approximately 60 countries. For more
information, visit the company's Website at www.amo-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements about AMO,
including statements by Mr. Rago relating to AMO's customer service
goals. All forward-looking statements in this press release represent
AMO's judgment only as of the date of this press release. Actual
results may differ from current expectations based on a number of
factors. Therefore, the reader is cautioned not to rely on these
forward-looking statements. AMO disclaims any intent or obligation to
update these forward-looking statements. Additional information
concerning these and other risk factors may be found in previous press
releases issued by AMO and AMO's public periodic filings with the
Securities and Exchange Commission, including the discussion under the
heading "Risk Factors" in AMO's 2007 Form 10-K filed in March 2008.
Copies of press releases and additional information about AMO are
available at www.amo-inc.com.
All trademarks, service marks and company names are the property
of their respective owners.